Guardant Health
GH
#1787
Rank
ยฃ8.36 B
Marketcap
ยฃ63.80
Share price
-3.96%
Change (1 day)
83.03%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of December 2025 : -ยฃ74.89 Million

According to Guardant Health 's latest financial reports the company has -ยฃ74.89 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$-ยฃ73.74 Million-33.74%
2024-12-31$-ยฃ0.12 Billion-189.34%
2023-12-31$ยฃ0.12 B150.39%
2022-12-31$ยฃ49.74 M-89.59%
2021-12-31$ยฃ0.47 B-51.95%
2020-12-31$ยฃ0.99 B53.79%
2019-12-31$ยฃ0.64 B56.37%
2018-12-31$ยฃ0.41 B81.11%
2017-12-31$ยฃ0.22 B253.53%
2016-12-31$ยฃ64.58 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Neogen
NEOG
ยฃ1.58 B-2,219.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
ยฃ1.29 B-1,824.36%๐Ÿ‡บ๐Ÿ‡ธ USA